Researchers have developed a new means of administering diabetes medication that might just make it easier for the body to accept the medication. That means? Injectable jelly. Yup. If proven successful, this could dramatically reduce the number of injections diabetics must receive to regulate their insulin levels.
According to Wired in the UK:
One hormone used by diabetics belongs to a class of medicines known as peptide drugs. As well as offering beneficial effects, peptide drugs are swiftly broken down and cleared by the human body. This means regular injections and fluctuating insulin levels can be a problem.
So, scientists have been developing an alternative means of administering peptides. What they’ve come up with is an injectable fusion protein that turns to jelly once it comes into contact with heat within the body. The jelly form makes the body absorb the enzymes more slowly, making the need for frequent injections much less.
Ashutosh Chilkoti, one of the Duke University researchers who worked on the medication, said:
Remarkably, a single injection of the GLP-1 POD was able to reduce blood glucose levels in mice for up to five days, which is 120 times longer than an injection of the peptide alone. For a patient with type 2 diabetes, it would be much more desirable to inject such a drug once a week or once a month rather than once or twice a day.
Sound great? I think so too. Another awesome aspect of this approach is that it’s apparently cheaper than traditional diabetes injections. Let’s hope this drug becomes available to the public soon, another weapon in the arsenal against growing diabetes rates.